Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01581294 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Norwegian Antirheumatic Drug Register

Study acronym: NOR-DMARD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description shortened, about 7 words
    • Site details revised at 4 of 6 sites
    • Collaborators: 4 to 5
    v5
  2. Re-verified, no change to tracked fieldsv4
  3. Study sites: 5 to 6v3
  4. Site details revised at 4 of 5 sitesv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Diakonhjemmet Hospital
25 trials monitored
See 1 trial at risk
Rheumatoid Arthritis
661 trials monitored
See 14 trials at risk
Psoriasis
591 trials monitored
See 24 trials at risk
Psoriatic Arthritis
212 trials monitored
See 9 trials at risk
and 1 more disease
NOR-DMARD is a register-based longitudinal observational study of which the main objectives are to study the effectiveness of treatment of inflammatory joint diseases with biological disease modifying anti-rheumatic drugs (DMARDs) in clinical practice, by measuring disease activity, health related quality of life, function and joint damage, and to study the long-term safety of such treatment. Other objectives include the assessment of cost-effectiveness of treatment, to identify and and validate clinical, genetic and immunological predictors of efficacy and adverse events, to assess the impact of treatment with biological DMARDs on work participation and work productivity, to investigate different strategies for use of biological DMARDs, to assess the performance of different outcome measures, and to ensure a systematic and timely follow-up of patients treated with biological DMARDs.
Trial Details
NCT Number NCT01581294
Lead Sponsor Diakonhjemmet Hospital
Collaborators: University Hospital of North Norway, St. Olavs Hospital, Lillehammer Hospital for Rheumatic Diseases, Vestre Viken Hospital Trust, Helse Forde
Conditions
(from sponsor)		 Inflammatory Joint Diseases
Related terms Arthritis, Psoriatic, Arthritis, Rheumatoid, Spondylarthritis, Spondylitis, Ankylosing
Enrollment 15,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov